Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, United States.
J Med Chem. 2022 Sep 22;65(18):12417-12426. doi: 10.1021/acs.jmedchem.2c01086. Epub 2022 Sep 13.
Trinucleotide repeat diseases such as myotonic dystrophy type 1 (DM1) and Huntington's disease (HD) are caused by expanded DNA repeats that can be used as templates to synthesize their own inhibitors. Because it would be particularly advantageous to reversibly assemble multivalent nucleic acid-targeting agents , we sought to develop a target-guided screen that uses dynamic covalent chemistry to identify multitarget inhibitors. We report the synthesis of a library of amine- or aldehyde-containing fragments. The assembly of these fragments led to a diverse set of hit combinations that was confirmed by matrix-assisted laser desorption/ionization-mass spectrometry (MALDI-MS) in the presence of DM1 and HD repeat sequences. Of interest for both diseases, the resulting hit combinations inhibited transcription selectively and in a cooperative manner , with inhibitory concentration (IC) values in the micromolar range. This dynamic covalent library and screening approach could be applied to identify compounds that reversibly assemble on other nucleic acid targets.
三核苷酸重复疾病,如肌强直性营养不良 1 型(DM1)和亨廷顿病(HD),是由可作为模板来合成自身抑制剂的扩展 DNA 重复引起的。因为可逆组装多价核酸靶向剂特别有利,所以我们试图开发一种基于靶标的筛选方法,该方法利用动态共价化学来识别多靶抑制剂。我们报告了含有胺或醛的片段文库的合成。这些片段的组装导致了一组多样化的命中组合,这在 DM1 和 HD 重复序列存在的情况下通过基质辅助激光解吸/电离-质谱(MALDI-MS)得到了证实。对于这两种疾病,所得到的命中组合都选择性地以协同方式抑制转录,其抑制浓度(IC)值在微摩尔范围内。这种动态共价文库和筛选方法可用于鉴定可逆组装在其他核酸靶标上的化合物。